Cargando…

Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional

[Image: see text]

Detalles Bibliográficos
Autor principal:	Imagawa, Akihisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	JDI Updates
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169369/ https://www.ncbi.nlm.nih.gov/pubmed/33098749 http://dx.doi.org/10.1111/jdi.13450

Ejemplares similares

New prospects for incretin‐related drugs in the treatment of type 2 diabetes
por: Kimura, Tomohiko, et al.
Publicado: (2020)

Cardiovascular disease in patients with type 2 diabetes
por: Jeon, Ja Young, et al.
Publicado: (2022)

A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis
por: Hotta, Nigishi
Publicado: (2019)

New perspective on type 2 diabetes, dyslipidemia and non‐alcoholic fatty liver disease
por: Matsuzaka, Takashi, et al.
Publicado: (2020)

Recent updates and future perspectives on gestational diabetes mellitus: An important public health challenge
por: Chu, Leo Check Hei, et al.
Publicado: (2021)

Dietary recommendations for type 2 diabetes patients: Lessons from recent clinical and basic research in Asia
por: Seino, Yusuke, et al.
Publicado: (2019)

In search of the optimal management strategy for non‐alcoholic fatty liver disease in type 2 diabetes patients
por: Lee, Chi‐Ho, et al.
Publicado: (2020)

SGLT2 inhibitors for genetic and acquired insulin resistance: Considerations for clinical use
por: Hosokawa, Yusei, et al.
Publicado: (2020)

Update on the efficacy and safety of sodium–glucose cotransporter 2 inhibitors in Asians and non‐Asians
por: Fujita, Yoshihito, et al.
Publicado: (2019)

Recent evidence in the etiology and treatment for diabetic kidney disease
por: Shikata, Kenichi
Publicado: (2020)

Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
por: Lin, Kuan‐Yu, et al.
Publicado: (2021)

Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
por: Nakamura, Toshihiro, et al.
Publicado: (2020)

Diabetic kidney disease: Its current trends and future therapeutic perspectives
por: Koya, Daisuke
Publicado: (2019)

Updates in diabetic neuropathy: A call for new diagnostic and treatment approaches
por: Aso, Yoshimasa
Publicado: (2021)

Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development
por: Himeno, Tatsuhito, et al.
Publicado: (2019)

One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives
por: Lui, David Tak Wai, et al.
Publicado: (2021)

Impaired insulin secretion and related factors in East Asian individuals
por: Nakamura, Akinobu, et al.
Publicado: (2021)

The journey to understanding incretin systems: Theory, practice and more theory
por: Yabe, Daisuke, et al.
Publicado: (2019)

Clinical evidence regarding factors linking metabolic abnormal obesity to pancreatic β‐cell dysfunction
por: Watada, Hirotaka
Publicado: (2020)

New perspectives on insulin therapy
por: Araki, Eiichi, et al.
Publicado: (2020)

Beginning of a new era in glucagon research: Breakthrough by the new glucagon assay
por: Kawamori, Dan
Publicado: (2020)

Obesity, metabolic syndrome and bariatric surgery: A narrative review
por: Jia, Weiping
Publicado: (2020)

Blood glucose control: Where are we?
por: Lee, Moon‐Kyu
Publicado: (2021)

“Preserved” glucagon secretion in fulminant type 1 diabetes
por: Murase‐Mishiba, Yuko, et al.
Publicado: (2018)

Immune checkpoint inhibitors-related pancreatitis with fulminant type 1 diabetes mellitus: case report and literature review
por: Fang, Wei, et al.
Publicado: (2023)

Re-Enlightenment of Fulminant Type 1 Diabetes under the COVID-19 Pandemic
por: Sano, Hiroyuki, et al.
Publicado: (2022)

Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)
por: Imagawa, Akihisa, et al.
Publicado: (2012)

Correlation of glycated albumin but not hemoglobin A(1c) with endogenous insulin secretion in fulminant type 1 diabetes mellitus
por: Koga, Masafumi, et al.
Publicado: (2010)

Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient‐derived induced pluripotent stem cells for future research
por: Hosokawa, Yoshiya, et al.
Publicado: (2019)

Two cases with fulminant type 1 diabetes that developed long after cessation of immune checkpoint inhibitor treatment
por: Hatayama, Satoko, et al.
Publicado: (2022)

Diagnostic criteria for acute‐onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus
por: Kawasaki, Eiji, et al.
Publicado: (2014)

Updates of incretin‐related drugs for the treatment of type 2 diabetes
por: Araki, Hirotaka, et al.
Publicado: (2022)

Fulminant type 1 diabetes mellitus: Two case reports
por: You, Wei, et al.
Publicado: (2019)

Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
por: Fujita, Yasunori, et al.
Publicado: (2023)

Fulminant type 1 diabetes mellitus in pregnancy
por: Li, Chun-Yu, et al.
Publicado: (2020)

Endogenous insulin secretion even at a very low level contributes to the stability of blood glucose control in fulminant type 1 diabetes
por: Shibasaki, Saeko, et al.
Publicado: (2010)

Update information on type 1 diabetes in children/adolescents and adults
por: Miura, Junnosuke, et al.
Publicado: (2023)

Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic origin
por: Qiu, Junlin, et al.
Publicado: (2022)

Differences in the Contribution of the CTLA4 Gene to Susceptibility to Fulminant and Type 1A Diabetes in Japanese Patients
por: Kawasaki, Eiji, et al.
Publicado: (2008)

Type 2 diabetes mellitus prevention strategy: Target and goal in Japanese men
por: Iwahashi, Hiromi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mpapjgrcji9r7g84ncdsn4j40i